Motherhood is a lifelong promise to love, protect and fight for your child. For some mothers, the greatest fight isn’t their own – it’s helping their child battle cancer.
Beginning today and throughout May, Northwestern Mutual, through its Foundation, is honoring heroic moms of childhood cancer patients by sharing their inspiring stories of strength. Additionally, the foundation is making a $50,000 grant in support of these moms to Alex’s Lemonade Stand Foundation (ALSF) to help find a cure.
Northwestern Mutual will share the personal stories of eight mothers and their children from across the country through a Facebook campaign.
To view the multimedia release go to:
http://www.multivu.com/players/English/7730651-northwestern-mutual-mothers-day/
Visit http://www.thankyoumum.org.au to send your mum a message of thanks! Thank
You Mum is all about giving thanks to the most important women in our
lives - our mums. Mothers hold a special and unique place in all of our
hearts, forming a bond unlike any other. In some parts of
the world however, this magical journey of pregnancy and childbirth is
often unplanned, life threatening and dangerous. Thank You Mum aims to
raise awareness of the importance of maternal health care for some of
the world\'s most vulnerable women.
Today the District of Columbia Department of Health (DOH) released a new report, “DC Takes On HIV: Public Awareness, Resident Engagement and a Call to Action,” which details the results of an extensive survey of residents’ awareness, knowledge, and behavior associated with the city’s five-year social marketing campaign for HIV prevention.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7379651-dc-department-of-health-study-shows-dc-takes-on-hiv-campaign-effective/
Third Box, a new resource for the unsure women in an unintended pregnancy, today announced results of a recent survey demonstrating that despite the current polarizing two-box political approaches, one in four women in unintended pregnancies are unsure of what to do. This data corresponds with the organization’s expansion of its reach to women in California regions, and its footprint across the country providing free medical and emotional care, in a space apart from ideology or politics, with no bias toward outcome.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7339251-third-box-sponsored-study-women-in-unintended-pregnancies-uncertain-national-expansion-campaign/
Es fácil dejarse llevar en las fiestas, especialmente en las comidas ricas que nos encantan. Este año te ayudaremos a tomar decisiones más balanceadas para el fin de año. Junto a Lipton® y Knorr® hemos creado versiones nutritivas de dos recetas navideñas, como el Ponche Mexicano para Navidad y el Sancocho, que deslumbrarán a tus amigos por su sabor y su presentación.
To view the multimedia release go to:
https://www.multivu.com/players/Spanish/8462251-unilever-foods-make-meals-that-do-more-during-the-holidays/
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
While January 1 is the traditional day millions announce their New Year’s Resolutions, research shows only 8% of Americans achieve success. For the fifth year, Life Time, is aiming to help people rethink resolutions and instead make a true, internal commitment to themselves to living a healthy way of life by participating in the Commitment Day 5K Fun Run and Walk. Held at more than 40 Life Time destinations across the U.S. and Canada, Commitment Day empowers individuals, families and communities to start the year on the right foot by marking their pledge with action toward a year of better health. New for 2017, a Virtual 5K is available for anyone in North America to join in. All participants will receive a race bib and commemorative Commitment Day tee shirt. Registration, locations and pricing details are available at www.CommitmentDay.com.
Commitment Weekend kicks off on Friday, Dec. 30 and continues through Monday, Jan. 2, when Life Time will open its doors to everyone – whether a member or not. During each of the four days, Life Time’s 122 destinations will feature a variety of health and fitness experiences and activities for all ages. In addition to the 5K Fun Run and Walk on Jan. 1, people can take part in unique-to-Life Time group fitness, indoor cycle and yoga classes such as Strike, Amp Cycle and Warrior Sculpt, as well as Alpha Training. Life Time’s indoor aquatic centers, basketball courts, rock walls and tennis, racquetball and squash courts will all be open with club-specific programming to help men, women and kids make their commitment even easier by doing activities they love or trying new things that will inspire them in the coming year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7991951-life-time-commitment-day-virtual-5k-fun-run-walk/
Every organ donor has the potential to save eight lives, which is the foundation of the new public awareness campaign from the Center for Organ Recovery & Education (CORE). Using multiple channels such as outdoor, television, print and radio advertising, transit wraps, a brand new website and social media, CORE is encouraging individuals to “LiVE: 8” and end the wait by signing up to become an organ and tissue donor.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7253051-center-for-organ-recovery-and-education-launches-live-8/
The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation.
A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in New York; MD Anderson Cancer Center in Houston; Fondazione Centro San Raffaele in Milan; and South Australian Health & Medical Research Institute in Adelaide.
This $40.3 million investment, comprised of 75 new research grants in LLS’s portfolio of 300 projects, will fund a diverse array of research to find better treatments and cures for patients with leukemia, lymphoma, myeloma and other blood cancers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554855-lls-invests-millions-new-research-treatment-cures/
An international survey conducted by GSK and released for World Meningitis Day shows gaps in the knowledge parents feel they have about meningococcal disease and its potential consequences. Almost 7 in 10 parents said they don’t know enough about the different strains of meningococcal disease and the potential damage they can cause. On average, more than half of parents were either unsure or unaware that there are different types of bacteria that cause the disease.
The survey of 5,000 parents in Brazil, Canada, Germany, Italy and Portugal also shows that out of a list of 14 vaccine-preventable diseases, meningococcal disease is considered by many parents to pose a top three health risk to their children. Fifty-seven percent listed meningococcal disease among the top three health conditions they considered of greatest risk to children followed by Hepatitis B at 34 percent, pneumococcal disease at 27 percent, polio at 25 percent, tetanus at 20 percent and pertussis at 17 percent.
A sudden, potentially life-threatening illness, meningococcal disease kills on average one person every eight minutes worldwide. It typically manifests as bacterial meningitis – an infection of the membrane around the brain and spine; or bacteraemia – a bloodstream infection. The disease progresses rapidly and it can lead to death within 24-48 hours of the first symptoms; globally up to 1 in 10 of those infected may die and in the US about 10-15 percent of people will die.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7814851-gsk-survey-world-meningitis-day/
